Basic Information
Tobira Therapeutics, headquartered in South San Francisco, is primarily engaged in the research, development, and commercialization of drugs for non-alcoholic steatohepatitis (NASH) and other liver diseases.
Tobira Therapeutics, Inc.
SanFrancisco,California,United States of America
15~50 people
January 01, 2006
jcrombie@tobiratherapeutics.com